4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-006043
CEO sold 12,279 shares at $3.31 ($40,668)
From the SEC's structured data for this filing
Trades in this filing
Shah Gaurav · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-13 | Sale : show line 1 in the form | −12,279 | $3.31 | $40,668 | 1,052,045 | D |
| Open-market sales · 12,279 sh · avg $3.31 · $40,668 | ||||||
Loading xslF345X05/form4.xml…